• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during breastfeeding and pregnancy is challenging for women with the condition. There are few data on how long-term exposure may affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological disorders such as hearing loss or impaired vision seizures, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are required.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication must consider the benefits of taking it against the potential risks to the baby. Physicians don't have the data to give clear advice however they can provide information on risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during early pregnancy were not at higher risk of fetal malformations or structural birth defects. Researchers conducted a large population-based case control study to assess the frequency of structural defects that were major in infants born to mothers who used stimulants during pregnancy. Clinical geneticists and pediatric cardiologists examined the cases to ensure an accurate case classification and to minimize the possibility of bias.

However, the researchers' study had its limitations. The most important issue was that they were not able to differentiate the effects of the medication from the underlying disorder. That limitation makes it difficult to know whether the small differences observed in the groups that were exposed are due to the use of medication or comorbidities that cause confusion. The researchers also did not study long-term outcomes for offspring.

The study did reveal that infants whose mothers took adhd medication for women medication during pregnancy were at a slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or had cut back on their medications used to treat adhd prior to or during pregnancy. This was due to central nervous system disorders, and the higher risk of admission was not found to be affected by the type of stimulant medication was used during pregnancy.

Women who took stimulant ADHD medication during pregnancy also had an elevated chance of having a caesarean delivery or having a baby born with low Apgar score (less than 7). These increases didn't seem to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the small risks posed by the use of ADHD medication during pregnancies in the early stages could be offset by the greater benefits for mother and baby of continuing treatment for the woman's condition. Physicians should discuss this with their patients and, where possible, assist them in developing strategies for improving their coping skills that may minimize the impact of her disorder on her daily life and relationships.

Interactions with Medication

More and more doctors are confronted with the dilemma of whether to continue treatment or stop as more women are diagnosed with ADHD. Often, these decisions are made in the absence of solid and reliable evidence regardless, so doctors have to weigh their experience from their own experiences, those of other doctors, and what medication is prescribed for adhd research says on the topic as well as their own best judgment for each individual patient.

Particularly, the issue of possible risks to the baby can be a challenge. Many studies on this subject are based on observations rather than controlled research, and their findings are often contradictory. Most studies focus on live births, which can underestimate the teratogenic impact that can lead to terminations or abortions of pregnancy. The study presented in this journal club addresses these shortcomings by looking at data from both live and deceased births.

Conclusion: While some studies have shown a positive correlation between ADHD medications and certain birth defects, other studies have not shown such a relationship. Most studies show that there is a neutral, or somewhat negative, impact. In the end, a careful risk/benefit analysis must be done in each case.

For women suffering from ADHD and ADD, the decision to stop taking medication is difficult if not impossible. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of isolation. In addition, a decrease in medication can interfere with the ability to do job-related tasks and drive safely which are essential aspects of daily life for many people with ADHD.

She suggests that women who are unsure about whether to keep or stop medication in light of their pregnancy should consider educating family members, friends and colleagues on the condition, its impact on daily functioning, and the advantages of staying on the current treatment regimen. It can also help women feel supported in her decision. It is important to remember that certain medications can be absorbed through the placenta so if a woman decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware that traces of the drug could be passed on to the baby.

Risk of Birth Defects

As the use and misuse of ADHD medication to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) is increasing the concern over the potential effects of these drugs on foetuses. A study that was published in the journal Molecular Psychiatry adds to the body of knowledge about this subject. Using two massive data sets researchers were able to look at more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. While the overall risk remains low, the scientists found that exposure in the first trimester to ADHD medications was linked to an increase in the risk of certain heart defects such as ventriculoseptal defect (VSD).

The researchers behind the study found no link between the use of early medications and other congenital anomalies, such as facial clefting or club foot. The results are in line with previous studies that have shown the presence of a small, but significant increase in the risk of developing cardiac malformations in women who started taking adhd medication weight Loss uk medications prior to the time of the time of pregnancy. This risk increased during the latter half of pregnancy, when a lot of women decided to stop taking their medication.

Women who took ADHD medication during the first trimester were more likely to require a caesarean birth or have a low Apgar after delivery and have a baby who needed help breathing after birth. The authors of the study were not able to remove bias in selection since they limited their study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope that their research will provide doctors with information when they see pregnant women. They recommend that, while the discussion of the benefits and risks is important but the decision to stop or continue treatment should be based on each woman's needs and the severity of her ADHD symptoms.

The authors also warn that, while stopping the medication is an option, it isn't a recommended practice because of the high incidence of depression and other mental health issues for women who are expecting or who are recently postpartum. Research has also shown that women who stop taking their medication will have a tough time adjusting to a life without them after the baby is born.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women with ADHD who must work through their symptoms while attending physician appointments as well as preparing for the arrival of their child and adjusting to new household routines may face a lot of challenges. This is why many women decide to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant drugs pass through breast milk in very small amounts, therefore the risk to the nursing infant is very low. The amount of exposure to medications can vary depending upon the dosage the medication is administered, its frequency and time of day. Additionally, individual medications enter the baby's system differently through the gastrointestinal tract and breast milk and the impact of this on a newborn isn't well known.

Because of the lack of research, some doctors may recommend stopping stimulant medication during a woman's pregnancy. This is a difficult decision for the patient, who must weigh the benefits of continuing her medication against the potential risks to the foetus. Until more information is available, GPs should ask all pregnant patients about their experience with ADHD and if they are planning or taking to take medication during the perinatal time.

Numerous studies have demonstrated that women can continue to take their adhd medication list uk medication in a safe manner while breastfeeding and during pregnancy. In response, a growing number of patients are choosing to continue their medication. They have concluded after consulting with their doctors that the benefits of retaining their current medication far outweigh any potential risks.

Women who suffer from ADHD who are planning to nurse should seek advice from a specialist psychiatrist prior to becoming pregnant. They should review their medications prescribed for adhd with their prescriber and discuss the advantages and disadvantages of continued treatment, including non-pharmacological management strategies. Psychoeducation should also be provided to help women with ADHD be aware of their symptoms and the underlying disorder Learn about the available treatment options and reinforce existing strategies for coping. This should be a multidisciplinary approach, which includes the GP doctors, obstetricians and psychiatrists. Pregnancy counselling should include discussion of a management plan for both the mother and child, and monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.